Inventor
CHIDAMBARAM NACHIAPPAN
FR75 patents
⚠️ This page may combine multiple inventors who share the name “CHIDAMBARAM NACHIAPPAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIPOCINE INC
44 patentsUS10226473B2Mar 12, 2019
High-strength testosterone undecanoate compositions
LIPOCINE INC23 citations98
US9949985B2Apr 24, 2018
High-strength testosterone undecanoate compositions
LIPOCINE INC23 citations98
US9757390B2Sep 12, 2017
High-strength testosterone undecanoate compositions
LIPOCINE INC27 citations98
US9480690B2Nov 1, 2016
High-strength testosterone undecanoate compositions
LIPOCINE INC34 citations98
US8865695B2Oct 21, 2014
Steroidal compositions
LIPOCINE INC37 citations98
US9943527B2Apr 17, 2018
High-strength testosterone undecanoate compositions
LIPOCINE INC18 citations94
US9358241B2Jun 7, 2016
High-strength testosterone undecanoate compositions
LIPOCINE INC31 citations94
US10973833B2Apr 13, 2021
High-strength testosterone undecanoate compositions
LIPOCINE INC8 citations92
US10716794B2Jul 21, 2020
High-strength testosterone undecanoate compositions
LIPOCINE INC9 citations92
US10022384B2Jul 17, 2018
17-hydroxyprogesterone ester-containing oral compositions and related methods
LIPOCINE INC10 citations92
US9498485B2Nov 22, 2016
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
LIPOCINE INC23 citations92
US9399069B2Jul 26, 2016
17-Hydroxyprogesterone ester containing oral compositions and related methods
LIPOCINE INC9 citations92
US11931367B2Mar 19, 2024
Oral (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate therapy
LIPOCINE INC7 citations86
US11672807B1Jun 13, 2023
Oral testosterone non-undecanoate therapy
LIPOCINE INC7 citations85
US11370811B1Jun 28, 2022
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use
LIPOCINE INC8 citations85
US11052096B2Jul 6, 2021
Steroidal compositions
LIPOCINE INC6 citations84
US10881670B2Jan 5, 2021
Oral testosterone tridecanoate therapy
LIPOCINE INC7 citations84
US10881671B2Jan 5, 2021
High-strength testosterone undecanoate compositions
LIPOCINE INC5 citations84
US10799513B2Oct 13, 2020
High-strength testosterone undecanoate compositions
LIPOCINE INC6 citations84
US10709716B2Jul 14, 2020
17-hydroxyprogesterone ester-containing oral compositions and related methods
LIPOCINE INC4 citations84
US9757389B2Sep 12, 2017
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
LIPOCINE INC8 citations84
US9364547B2Jun 14, 2016
17-hydroxyprogesterone ester containing oral compositions and related methods
LIPOCINE INC7 citations84
US9358298B2Jun 7, 2016
17-hydroxyprogesterone ester containing oral compositions and related methods
LIPOCINE INC7 citations84
US9358299B2Jun 7, 2016
17-hydroxyprogesterone ester-containing oral compositions and related methods
LIPOCINE INC7 citations84
US12156881B2Dec 3, 2024
Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy
LIPOCINE INC3 citations75
US12208103B1Jan 28, 2025
Compositions and methods for treating CNS disorders
LIPOCINE INC2 citations73
US11872235B1Jan 16, 2024
Bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters
LIPOCINE INC1 citations73
US11364249B2Jun 21, 2022
High-strength testosterone undecanoate compositions
LIPOCINE INC1 citations73
US11364250B2Jun 21, 2022
High-strength testosterone undecanoate compositions
LIPOCINE INC1 citations73
US11311555B2Apr 26, 2022
High-strength testosterone undecanoate compositions
LIPOCINE INC1 citations73
US11298365B2Apr 12, 2022
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
LIPOCINE INC2 citations73
US10561615B2Feb 18, 2020
Testosterone undecanoate compositions
LIPOCINE INC5 citations73
US12186327B2Jan 7, 2025
Oral allopregnanolone compositions and methods of use
LIPOCINE INC2 citations72
US12161651B1Dec 10, 2024
Oral testosterone therapy
LIPOCINE INC1 citations72
US11992496B1May 28, 2024
Oral testosterone therapy
LIPOCINE INC2 citations72
US11969434B1Apr 30, 2024
Oral allopregnanolone compositions and methods of use
LIPOCINE INC4 citations72
US11478485B1Oct 25, 2022
Compositions and methods for treating CNS disorders
LIPOCINE INC3 citations72
US11337987B1May 24, 2022
Compositions and methods for treating central nervous system disorders
LIPOCINE INC5 citations72
US12409185B1Sep 9, 2025
Oral allopregnanolone compositions and methods of use
LIPOCINE INC1 citations62
US12351600B2Jul 8, 2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use
LIPOCINE INC0 citations62
US12318396B1Jun 3, 2025
Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy
LIPOCINE INC0 citations62
US12310978B2May 27, 2025
Composition and method for oral delivery of androgen prodrugs
LIPOCINE INC0 citations62
US12303517B1May 20, 2025
Oral testosterone therapy
LIPOCINE INC0 citations62
US12171770B1Dec 24, 2024
Bioavailable solid state (17-beta)-hydroxy-4-androsten-3-one esters
LIPOCINE INC0 citations62
GILIYAR CHANDRASHEKAR
2 patentsBANNER PHARMACAPS INC
2 patentsHASSAN EMADELDIN M
1 patentAPPLE INC
1 patentShowing the top 50 of 75 patents by PatentIndex Score.